Eli Lilly Shares Acquired by World Investment Advisors

Institutional investor increases stake in pharmaceutical giant

Mar. 29, 2026 at 11:42am

World Investment Advisors, a major institutional investor, has increased its position in shares of pharmaceutical company Eli Lilly and Company (NYSE: LLY) by 17.2% during the fourth quarter, according to a recent SEC filing. The firm now owns 24,198 shares of Lilly's stock, valued at over $26 million.

Why it matters

Eli Lilly is one of the world's largest pharmaceutical companies, known for developing innovative drugs and treatments. This acquisition by a major institutional investor signals continued confidence in Lilly's long-term growth potential and ability to deliver returns for shareholders.

The details

According to the SEC filing, World Investment Advisors purchased an additional 3,552 shares of Eli Lilly stock during the fourth quarter, increasing its total position to 24,198 shares. This represents a 17.2% increase in the firm's holdings of Lilly stock compared to the previous reporting period.

  • World Investment Advisors filed the SEC report disclosing the increased Eli Lilly stake on March 29, 2026.
  • The transactions occurred during the fourth quarter of 2025.

The players

World Investment Advisors

A major institutional investment firm that manages a diversified portfolio of stocks, bonds, and other assets on behalf of its clients.

Eli Lilly and Company

A global pharmaceutical company headquartered in Indianapolis, Indiana, known for developing innovative drugs and treatments across a range of therapeutic areas.

Got photos? Submit your photos here. ›

The takeaway

This acquisition by a prominent institutional investor underscores the continued confidence in Eli Lilly's long-term growth prospects within the pharmaceutical industry. As Lilly continues to develop new drugs and expand its global footprint, its stock remains an attractive investment for major funds seeking exposure to the healthcare sector.